A living cell-based fluorescent reporter for high-throughput screening of anti-tumor drugs

Suppression of cellular O-linked 13-N-acetylglucosaminylation (O-GlcNAcylation) can repress proliferation and migration of various cancer cells, which opens a new avenue for cancer therapy. Based on the regulation of insulin gene transcription, we designed a cell-based fluorescent reporter capable of sensing cellular O-GlcNAcylation in HEK293T cells. The fluorescent reporter mainly consists of a reporter (green fluorescent protein (GFP)), an internal reference (red fluorescent protein), and an operator (neuronal differentiation 1), which serves as a sweet switch to control GFP expression in response to cellular OGlcNAcylation changes. The fluorescent reporter can efficiently sense reduced levels of cellular OGlcNAcylation in several cell lines. Using the fluorescent reporter, we screened 120 natural products and obtained one compound, sesamin, which could markedly inhibit protein O-GlcNAcylation in HeLa and human colorectal carcinoma-116 cells and repress their migration in vitro. Altogether, the present study demonstrated the development of a novel strategy for anti-tumor drug screening, as well as for conducting gene transcription studies. (c) 2021 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Automated summary

Inhibition of cellular O-GlcNAcylation can suppress proliferation and migration of cancer cells, leading to a new avenue for cancer therapy. A cell-based fluorescent reporter was developed to sense changes in cellular O-GlcNAcylation, allowing for identification of natural compounds such as sesamin that inhibit O-GlcNAcylation and migration of cancer cells.